37 studies found for:    " January 13, 2014":" February 12, 2014"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Enrolling by invitation Comprehensive HIV Prevention Package for MSM in Southern Africa: Pilot Study (Sibanye Health Project)
Condition: HIV
Interventions: Behavioral: Condom choices;   Behavioral: Condom-compatible lubricant choices;   Behavioral: Couples HIV counseling and testing (CVCT);   Drug: Pre-exposure prophylaxis with FTC/TDF;   Other: Staff and provider MSM and LGBT sensitization training;   Behavioral: HIV Testing and Risk-reduction counseling;   Behavioral: Linkage to care
22 Recruiting Increasing Motivation for Antiretroviral Therapy Initiation: A Pilot Intervention
Condition: HIV
Interventions: Behavioral: PATCH;   Behavioral: SRS
23 Completed Observational, Retrospective, Multicenter Study to Describe the Reasons for the Change of the Regimen of Antiretroviral Therapy in HIV Patients
Condition: HIV
Intervention:
24 Available Prevention of Transmission of Sexually Transmitted Diseases in the Youth Through Effective Intervention,
Condition: HIV
Intervention: Behavioral: Lifestyle Counseling
25 Not yet recruiting Parenting Mindfully Study
Conditions: Substance Abuse;   HIV Risk
Interventions: Behavioral: Parenting Mindfully Program;   Other: Parent Education Program
26 Recruiting Assessing the Severity of Metabolic-related Liver Injuries in Aging HIV-monoinfected Patients
Conditions: HIV Infection;   Liver Injuries
Intervention: Procedure: MRI and biopsy
27 Active, not recruiting Safety, Tolerability and Immunogenicity Induced by the THV01 Treatment in Patients Infected With HIV-1 Clade B and Treated With Highly Active Antiretroviral Therapy (HAART).
Condition: HIV Infection
Interventions: Biological: THV01-1;   Biological: THV01-2;   Biological: Placebo
28 Not yet recruiting Imiquimod, Fluorouracil, or Observation in Treating Patients With High-Grade Anal Squamous Skin Lesions Who Are HIV-Positive
Conditions: Anal Intraepithelial Neoplasia;   High-grade Squamous Intraepithelial Lesion;   HIV Infection
Interventions: Drug: imiquimod;   Drug: fluorouracil;   Other: questionnaire administration;   Other: laboratory biomarker analysis
29 Recruiting Randomized, Open-label Phase II Trial to Assess the Safety and Immunogenicity of MVA-BN Smallpox Vaccine in Immunocompromised Subjects With HIV Infection
Condition: Smallpox
Intervention: Biological: MVA-BN® smallpox vaccine
30 Not yet recruiting Switching From Efavirenz/Atripla to Rilpivirine Among Patients With Neurocognitive or Neuropsychological Side Effects
Conditions: Impaired Cognition;   Depression/Anxiety;   Poor Quality Sleep;   Quality of Life;   HIV-1 Infection
Interventions: Drug: Immediate switch to TDF/FTC/RPV;   Drug: Switch to TDF/FTC/RPV after 12 weeks
31 Completed Immune Reconstitution to Measles Virus of HIV Infected Children in Zambia
Condition: Measles
Intervention: Drug: Measles vaccine
32 Completed Evaluation of PTB Screening in ANC in Lusaka, Zambia
Condition: Pulmonary Tuberculosis
Interventions: Other: TB screening Questionnaire;   Other: Sputum smear and culture (only in HIV negative women who are symptomatic)
33 Completed Enhanced TB Screening to Determine the Prevalence and Incidence of TB in Patients With HIV
Condition: Tuberculosis
Intervention: Other: Comprehensive TB screening
34 Recruiting International Latino Research Partnership
Condition: Substance Use (Drugs, Alcohol)
Intervention: Behavioral: Integrated Intervention for Dual Problems and Early Action
35 Completed A Feasibility Study to Assess Tenofovir and Maraviroc Protection Against HIV-1 in Cervical and Vaginal Explants
Condition: Healthy Adult Females
Interventions: Drug: Tenofovir;   Drug: Maraviroc
36 Active, not recruiting Comparative Trial of Antidepressant Treatment Models in HIV Care in Uganda
Condition: Depression
Intervention: Drug: antidepressant therapy
37 Recruiting CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant
Conditions: Chronic Myeloid Leukemia (CML);   Acute Myelogenous Leukemia (AML);;   Myelodysplastic Syndrome (MDS);;   Juvenile Myelomonocytic Leukemia (JMML);;   Acute Lymphoblastic Leukemia (ALL);;   Lymphoma (Hodgkin's and Non-Hodgkin's)
Interventions: Device: CliniMACS CD34+ Reagent System;   Drug: Thiotepa;   Drug: Cyclophosphamide;   Drug: Alemtuzumab;   Drug: Tacrolimus;   Drug: Melphalan;   Drug: Busulfan;   Drug: Fludarabine;   Drug: Methylprednisolone

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-37) Next Page   
Indicates status has not been verified in more than two years